The synthesis of oxime-linked mucin mimics was accomplished via the incorporation of multiple ketone residues into a peptide followed by reaction with aminooxy sugars corresponding to the tumor-related TN and sialyl TN (STN) antigens.
The site-specific attachment of oligosaccharides to proteins can be accomplished by reaction of nucleophilic sugar derivatives with aldehydes and ketones. 1 Previously, we reported on the use of ketone-amino acid 1 (Figure 1 ) for the synthesis of glycopeptide analogs containing unnatural sugar-peptide linkages. of the ketone group.
4
The ketone group is chemically orthogonal to all naturally occurring amino acid side chain functional groups and thus can be selectively condensed with aminooxy sugars to give the corresponding oximelinked products (4). Since glycoproteins often contain more than one site of glycosylation, we were interested to see if this strategy could be applied to the synthesis of glycopeptides with clustered oxime-linked glycans.
Mucins are a class of heavily O-glycosylated proteins that are abundantly secreted by epthelial cells specialized for mucus production.
5
They are rich in serine and threonine residues bearing α-linked glycans initiated by Nacetylgalactosamine (GalNAc). A variety of carbohydrate ligands required for cell-surface interactions, including the Lewis and blood group antigens, can be presented on a mucin scaffold. In cancer cells, the glycosylation pattern of mucins is altered, leading to the expression of distinct tumor-related epitopes.
6 Thus, mucin fragments and their cancer-associated oligosaccharides have attracted much attention as components of synthetic cancer vaccines.
7 In the present study we focused on the preparation of oximelinked mucin mimics containing clusters of the T N and sialyl T N (ST N ) antigens 8 ( Figure 2 ), which are abundantly expressed in many types of cancer, including tumors of the breast, colon, liver and pancreas. We chose fragments of the endothelial mucin GlyCAM-1 (5 and 6, Figure 3 ) as peptide scaffolds.
10 Peptides 5 and 6 each replace six Ser or Thr residues within the 12-or 17-amino acid sequence with amino acid 1 (designated with the single letter code "O"). The syntheses of 5 and 6 were carried out on an automated peptide synthesizer using DCC/HOBt mediated couplings, on MBHA and FmocGlu(tBu)-Wang resins, respectively. Amino acid 1 was used without protection of the ketone group. Following chain assembly the peptides were cleaved from the resin with 95% aqueous TFA for 5 hours and precipitated from Et 2 O. Analysis of the crude peptides by ESI-MS showed the desired ketone-containing derivatives as the major products.
11 Purification of the peptides by reversed-phase HPLC yielded targets 5 and 6 in 40-46% yield. The synthesis of the aminooxy T N antigen (7) was accomplished as previously described 2 using a phase transfer catalyzed (PTC) 12 reaction of Nhydroxysuccinimide (NHS) with glycosyl chloride 8 13 (Scheme 1). Reductive acetylation of 9, followed by mild hydrazinolysis afforded the desired aminooxy sugar (7). We have recently found that the intermediate NHS glycoside (9) can also be accessed using glycosyl bromide 10 13 as a donor in a Koenigs-Knorr glycosylation with NHS. While the stereoselectivity of this reaction is not as high as that achieved in the PTC reaction, the preparation of the α-bromide is generally higher yielding than the β-chloride (95% versus 45%) 13 making this route an attractive alternative. The synthesis of aminooxy-ST N 11 utilized the selectively-protected glycosyl acceptor (12), containing the pre-installed NHS glycoside, for reaction with known sialyl phosphite 13 14 (Figure 4 ). For the installation of the NHS glycoside we chose to use a Koenigs-Knorr glycosylation with glycosyl bromide 14, which was obtained from 6-O-TBDPS-D-galactal (15).
15
As depicted in Scheme 2, glycosyl bromide 14 was generated in three steps via iosopropylidine formation, azidonitration 12 with CAN and NaN 3 and treatment with LiBr. Reaction of bromide 14 with NHS in the presence of AgClO 4 gave compound 16 in 65% yield as a mixture of anomers (3:1 α/β). Isolation of the desired α-glycoside (12) was achieved following removal of the TBDPS group with TBAF. Glycosylation of 12 with sialyl phosphite 13 using TMSOTf as the promoter gave disaccharide 17 in 44% yield as a mixture of anomers (3:1 α/β). Subsequent deprotection and reductive acetylation of 17 over a series of steps afforded the target aminooxy-ST N 11. n., 60%; (h) Ac2O, pyridine, DMAP, rt, o.n., 54%; (i) H2, Pd/C, Ac2O, rt, 2 h, 49% after HPLC; (j) i) NaOMe, MeOH, rt, 24 h, ii) LiOH, MeOH, H2O, 4 °C, o.n., iii) 10% aq. N2H4·H2O, 70% for 3 steps.
